Intravenous Methylprednisolone Reduces the Risk of Propofol-Induced Adverse Effects During Wada Testing

DOI Web Site 1 Citations 23 References

Search this article

Abstract

The adverse effects and risks associated with intracarotid propofol injection during Wada testing were retrospectively compared in two groups of patients with (n = 75) and without (n = 58) intravenous methylprednisolone administered before intracarotid propofol injection. The incidences of all adverse effects were decreased in the methylprednisolone group. In particular, severe adverse effects such as increased muscle tone with twitching and rhythmic movements or tonic posture, which could adversely affect Wada test results, were seen in one patient in the methylprednisolone group and seven patients in the control group, indicating 92% risk reduction. This study suggests that Wada testing using intravenous methylprednisolone administration prior to propofol injection is a safe approach to the preoperative evaluation of brain tumors, epilepsy, and arteriovenous malformations.<br>

Journal

Citations (1)*help

See more

References(23)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top